CAM

Cormorant Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-25,000	Closed	-$2.16M	–	79
2020 Q1	$2.16M	Sell	25,000 -14,300	-36%	-$1.24M	0.1%	63
2019 Q4	$4.22M	Hold	39,300	–	–	0.17%	58
2019 Q3	$3.54M	Sell	39,300 -10,700	-21%	-$964K	0.22%	55
2019 Q2	$4.22M	Sell	50,000 -40,000	-44%	-$3.38M	0.24%	57
2019 Q1	$7.93M	Sell	90,000 -128,222	-59%	-$11.3M	0.54%	45
2018 Q4	$15.6M	Buy	218,222 +43,222	+25%	+$3.09M	1.27%	30
2018 Q3	$21.5M	Sell	175,000 -16,112	-8%	-$1.98M	1.4%	25
2018 Q2	$18.8M	Hold	191,112	–	–	1.39%	25
2018 Q1	$15.8M	Sell	191,112 -8,888	-4%	-$737K	1.18%	20
2017 Q4	$15.5M	Sell	200,000 -50,000	-20%	-$3.88M	1.62%	18
2017 Q3	$15.3M	Hold	250,000	–	–	2.71%	12
2017 Q2	$11.5M	Sell	250,000 -50,000	-17%	-$2.3M	1.91%	19
2017 Q1	$13M	Sell	300,000 -59,000	-16%	-$2.55M	1.89%	21
2016 Q4	$13.9M	Sell	359,000 -39,301	-10%	-$1.52M	1.87%	18
2016 Q3	$20.2M	Hold	398,301	–	–	2.22%	16
2016 Q2	$18.1M	Sell	398,301 -205,599	-34%	-$9.34M	2.57%	13
2016 Q1	$23.9M	Hold	603,900	–	–	3.6%	8
2015 Q4	$34.2M	Sell	603,900 -115,000	-16%	-$6.51M	4.09%	5
2015 Q3	$28.6M	Hold	718,900	–	–	4.57%	3
2015 Q2	$34.3M	Hold	718,900	–	–	4.56%	6
2015 Q1	$28.5M	Sell	718,900 -281,100	-28%	-$11.2M	4.41%	6
2014 Q4	$22.3M	Buy	1,000,000 +150,000	+18%	+$3.35M	3.44%	6
2014 Q3	$13.3M	Buy	850,000 +550,000	+183%	+$8.62M	2.74%	7
2014 Q2	$4.45M	Buy	+300,000	New	+$4.45M	1.18%	33